局部晚期-话题@MedSci

#局部晚期#

176篇内容 | 1695人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1650741, encodeId=9c331650e4120, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=BJC：S-1加顺铂联合同步放疗治疗局部晚期不可切除的非小细胞肺癌, objectType=article, longId=150145, objectId=086e15014582, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=086e15014582, replyNumber=0, likeNumber=36, createdTime=2019-07-13, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=086e15014582, moduleTitle=BJC：S-1加顺铂联合同步放疗治疗局部晚期不可切除的非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=086e15014582)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650749, encodeId=b2cc1650e4902, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=LANCET ONCOL:《柳叶刀》子刊公布FLOT4总生存结果：局部晚期胃或胃食管交界部腺癌围术期化疗FLOT优于ECF/ECX, objectType=article, longId=164686, objectId=6f471646868d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f471646868d, replyNumber=0, likeNumber=32, createdTime=2019-09-25, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f471646868d, moduleTitle=LANCET ONCOL:《柳叶刀》子刊公布FLOT4总生存结果：局部晚期胃或胃食管交界部腺癌围术期化疗FLOT优于ECF/ECX, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f471646868d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650758, encodeId=e4951650e5844, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=Lancet Oncol：首创新药氧化铪纳米颗粒NBTXR3可以提高新辅助放疗治疗局部晚期软组织肉瘤的疗效, objectType=article, longId=175185, objectId=ed911e5185bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed911e5185bf, replyNumber=0, likeNumber=39, createdTime=2019-11-26, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed911e5185bf, moduleTitle=Lancet Oncol：首创新药氧化铪纳米颗粒NBTXR3可以提高新辅助放疗治疗局部晚期软组织肉瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed911e5185bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650748, encodeId=2fe81650e4896, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=SCI REP：平均血小板体积对放化疗局部晚期非小细胞肺癌的预后意义, objectType=article, longId=161979, objectId=55b31619e952, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55b31619e952, replyNumber=0, likeNumber=32, createdTime=2019-11-06, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55b31619e952, moduleTitle=SCI REP：平均血小板体积对放化疗局部晚期非小细胞肺癌的预后意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55b31619e952)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650740, encodeId=95e31650e40d5, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=FDA批准辉瑞EGFR抑制剂达克替尼用于EGFR突变的局部晚期或转移性NSCLC患者的一线治疗, objectType=article, longId=149971, objectId=bdf71499e193, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdf71499e193, replyNumber=0, likeNumber=26, createdTime=2019-08-17, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdf71499e193, moduleTitle=FDA批准辉瑞EGFR抑制剂达克替尼用于EGFR突变的局部晚期或转移性NSCLC患者的一线治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdf71499e193)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650752, encodeId=09371650e5251, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=无法手术的晚期肺癌患者生存结果大不同——局部晚期&转移性晚期肺癌, objectType=article, longId=167387, objectId=5acb16e38737, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5acb16e38737, replyNumber=0, likeNumber=32, createdTime=2019-12-02, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5acb16e38737, moduleTitle=无法手术的晚期肺癌患者生存结果大不同——局部晚期&转移性晚期肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5acb16e38737)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650745, encodeId=c4151650e456a, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=PLos One：肿瘤周围放射学特征可以预测局部晚期NSCLC的远处转移, objectType=article, longId=152992, objectId=0ac015299265, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ac015299265, replyNumber=0, likeNumber=40, createdTime=2018-12-04, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ac015299265, moduleTitle=PLos One：肿瘤周围放射学特征可以预测局部晚期NSCLC的远处转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ac015299265)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650746, encodeId=a9001650e4634, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=CHMP：Kisqali联合疗法扩展至所有HR + / HER2-局部晚期或转移性乳腺癌的女性, objectType=article, longId=153910, objectId=a18915391059, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a18915391059, replyNumber=0, likeNumber=40, createdTime=2019-06-22, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a18915391059, moduleTitle=CHMP：Kisqali联合疗法扩展至所有HR + / HER2-局部晚期或转移性乳腺癌的女性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a18915391059)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650742, encodeId=81131650e42a0, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=CLIN CANCER RES：奥拉帕尼联合西妥昔单抗及放疗治疗局部晚期头颈部肿瘤, objectType=article, longId=152302, objectId=ed0e152302b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed0e152302b7, replyNumber=0, likeNumber=36, createdTime=2019-01-05, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed0e152302b7, moduleTitle=CLIN CANCER RES：奥拉帕尼联合西妥昔单抗及放疗治疗局部晚期头颈部肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed0e152302b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650735, encodeId=77621650e351a, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=JAMA ONCOL：完全新辅助疗法治疗局部晚期直肠癌, objectType=article, longId=133602, objectId=4d9513360212, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d9513360212, replyNumber=0, likeNumber=29, createdTime=2018-07-06, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d9513360212, moduleTitle=JAMA ONCOL：完全新辅助疗法治疗局部晚期直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d9513360212)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650743, encodeId=d72a1650e4304, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=CLIN CANCER RES：骨骼肌损失可以作为局部晚期宫颈癌患者预后的标志, objectType=article, longId=152333, objectId=397315233363, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=397315233363, replyNumber=0, likeNumber=35, createdTime=2019-02-16, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=397315233363, moduleTitle=CLIN CANCER RES：骨骼肌损失可以作为局部晚期宫颈癌患者预后的标志, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=397315233363)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650736, encodeId=a7ad1650e3654, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=病例分析丨局部晚期直肠癌治疗，如何很大程度提高pCR率？, objectType=article, longId=144558, objectId=73ca14455892, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73ca14455892, replyNumber=0, likeNumber=33, createdTime=2019-03-13, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73ca14455892, moduleTitle=病例分析丨局部晚期直肠癌治疗，如何很大程度提高pCR率？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73ca14455892)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650738, encodeId=81ba1650e3893, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=局部晚期直肠癌1例, objectType=article, longId=146945, objectId=2aac146945ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2aac146945ae, replyNumber=0, likeNumber=35, createdTime=2019-02-17, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2aac146945ae, moduleTitle=局部晚期直肠癌1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2aac146945ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650733, encodeId=cfb31650e3351, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=J Thorac Oncol：局部晚期NSCLC的首发失败部位风险模型, objectType=article, longId=129979, objectId=54b71299e923, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54b71299e923, replyNumber=0, likeNumber=36, createdTime=2018-06-05, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54b71299e923, moduleTitle=J Thorac Oncol：局部晚期NSCLC的首发失败部位风险模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54b71299e923)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650737, encodeId=1c1b1650e376d, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=JCO：局部晚期食管鳞状细胞癌新辅助放化疗联合手术与单纯手术治疗效果比较, objectType=article, longId=146659, objectId=18ba1466595a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18ba1466595a, replyNumber=0, likeNumber=25, createdTime=2019-01-03, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18ba1466595a, moduleTitle=JCO：局部晚期食管鳞状细胞癌新辅助放化疗联合手术与单纯手术治疗效果比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18ba1466595a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650734, encodeId=08a01650e3417, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=JCO：局部晚期HCC患者是否推荐放射性栓塞治疗, objectType=article, longId=132144, objectId=b8ed13214436, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8ed13214436, replyNumber=0, likeNumber=36, createdTime=2018-09-15, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8ed13214436, moduleTitle=JCO：局部晚期HCC患者是否推荐放射性栓塞治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8ed13214436)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650726, encodeId=46961650e2659, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=【ESMO Asia】PACIFIC研究：Durvalumab显著延长局部晚期NSCLC的PFS, objectType=article, longId=120733, objectId=d89c120e33b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d89c120e33b7, replyNumber=0, likeNumber=36, createdTime=2017-11-25, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d89c120e33b7, moduleTitle=【ESMO Asia】PACIFIC研究：Durvalumab显著延长局部晚期NSCLC的PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d89c120e33b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650724, encodeId=c72b1650e2466, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=Lancet Oncol：局部晚期和不能手术的肝细胞癌——索拉菲尼vs钇-90内放射治疗, objectType=article, longId=117846, objectId=a85011e846a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a85011e846a9, replyNumber=0, likeNumber=48, createdTime=2018-08-02, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a85011e846a9, moduleTitle=Lancet Oncol：局部晚期和不能手术的肝细胞癌——索拉菲尼vs钇-90内放射治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a85011e846a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650728, encodeId=fbd81650e28d2, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=J Clin Oncol：顺铂放化疗治疗局部晚期头颈癌：每周一次好还是每周三次好？, objectType=article, longId=124124, objectId=0703124124e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0703124124e3, replyNumber=0, likeNumber=40, createdTime=2018-06-25, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0703124124e3, moduleTitle=J Clin Oncol：顺铂放化疗治疗局部晚期头颈癌：每周一次好还是每周三次好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0703124124e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1650727, encodeId=c3f51650e2712, content=<a href='/topic/show?id=ffae4e614b6' target=_blank style='color:#2F92EE;'>#局部晚期#</a>, objectTitle=JAMA SURGERY：新辅助化疗联合放疗与单纯新辅助化疗对比治疗局部晚期膀胱癌, objectType=article, longId=121890, objectId=32f8121890c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32f8121890c2, replyNumber=0, likeNumber=29, createdTime=2018-02-25, rootId=0, userName=yhy100208, userId=901d24099859, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32f8121890c2, moduleTitle=JAMA SURGERY：新辅助化疗联合放疗与单纯新辅助化疗对比治疗局部晚期膀胱癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32f8121890c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

局部晚期

2020-05-29

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

BJC：S-1加顺铂联合同步放疗治疗局部晚期不可切除的非小细胞肺癌

2019-07-13

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

LANCET ONCOL:《柳叶刀》子刊公布FLOT4总生存结果：局部晚期胃或胃食管交界部腺癌围术期化疗FLOT优于ECF/ECX

2019-09-25

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

Lancet Oncol：首创新药氧化铪纳米颗粒NBTXR3可以提高新辅助放疗治疗局部晚期软组织肉瘤的疗效

2019-11-26

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

SCI REP：平均血小板体积对放化疗局部晚期非小细胞肺癌的预后意义

2019-11-06

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

FDA批准辉瑞EGFR抑制剂达克替尼用于EGFR突变的局部晚期或转移性NSCLC患者的一线治疗

2019-08-17

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

无法手术的晚期肺癌患者生存结果大不同——局部晚期&转移性晚期肺癌

2019-12-02

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

PLos One：肿瘤周围放射学特征可以预测局部晚期NSCLC的远处转移

2018-12-04

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

CHMP：Kisqali联合疗法扩展至所有HR + / HER2-局部晚期或转移性乳腺癌的女性

2019-06-22

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

CLIN CANCER RES：奥拉帕尼联合西妥昔单抗及放疗治疗局部晚期头颈部肿瘤

2019-01-05

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

JAMA ONCOL：完全新辅助疗法治疗局部晚期直肠癌

2018-07-06

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

CLIN CANCER RES：骨骼肌损失可以作为局部晚期宫颈癌患者预后的标志

2019-02-16

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

病例分析丨局部晚期直肠癌治疗，如何很大程度提高pCR率？

2019-03-13

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

局部晚期直肠癌1例

2019-02-17

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

J Thorac Oncol：局部晚期NSCLC的首发失败部位风险模型

2018-06-05

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

JCO：局部晚期食管鳞状细胞癌新辅助放化疗联合手术与单纯手术治疗效果比较

2019-01-03

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

JCO：局部晚期HCC患者是否推荐放射性栓塞治疗

2018-09-15

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

【ESMO Asia】PACIFIC研究：Durvalumab显著延长局部晚期NSCLC的PFS

2017-11-25

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

Lancet Oncol：局部晚期和不能手术的肝细胞癌——索拉菲尼vs钇-90内放射治疗

2018-08-02

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

J Clin Oncol：顺铂放化疗治疗局部晚期头颈癌：每周一次好还是每周三次好？

2018-06-25

yhy100208 (审核中...)

前往app查看评论内容

#局部晚期#

JAMA SURGERY：新辅助化疗联合放疗与单纯新辅助化疗对比治疗局部晚期膀胱癌

2018-02-25

科室
- - 订阅+
  - 更多科室
工具
服务